Navigation Links
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Date:3/24/2009

ABBOTT PARK, Ill., March 24 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced the initiation of the next phase of the ABSORB clinical trial to evaluate the safety and performance of the company's fully bioabsorbable drug eluting coronary stent. This second phase of the ABSORB clinical trial will enroll approximately 80 patients at 10 centers in Europe, Australia and New Zealand, and will incorporate device enhancements designed to improve deliverability and vessel support. The first patient was enrolled into the second stage of the ABSORB clinical trial at Onze Lieve Vrouw Ziekenhuis Hospital in Aalst, Belgium, by Bernard De Bruyne, M.D., Ph.D.

"Interventional cardiology has come a long way. It started with balloon angioplasty, which evolved into bare metal stents and then drug eluting metal stents were created," said Patrick W. Serruys, M.D., Ph.D., professor of interventional cardiology at the Thoraxcentre, Erasmus University Hospital, Rotterdam, and principal investigator of the ABSORB trial. "Now we have the fourth revolution in interventional cardiology technology, and patient outcomes from the first stage of ABSORB clearly show that bioabsorbable devices are the future of coronary artery disease treatment."

Results from the first stage of the ABSORB trial with 30 patients demonstrated that Abbott's bioabsorbable everolimus eluting stent successfully treated coronary artery disease, and that at two years, the treated vessel was able to expand and contract, without being restricted by a permanent implant - indicating that the device was absorbed. In addition, there were no cases of thrombosis (blood clot formation) out to two years of follow-up, and no new major adverse cardiac events (MACE) between six months and two years, with the bioabsorbable device demonstrat
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
2. Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor
3. Abbott Receives Complete Response Letter From FDA for Controlled-Release Hydrocodone With Acetaminophen
4. Abbotts XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
5. Continuous Treatment With Abbotts HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
6. Abbotts Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines
7. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
8. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
9. Abbott Presents Long-Term Data From Extension Study Showing Adult Crohns Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
10. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)...  On Oct. 2, some 24,000 Lilly employees spanning ... Global Day of Service. Building on Lilly,s strong heritage ... a single, coordinated effort to improve the communities where ... so proud of this tradition, and of our Lilly ... the communities around the world where we live and ...
(Date:9/29/2014)... 2014 Kush Bottles, North America,s ... and consulting services for the medical and recreational marijuana ... has assumed the role of Chief Executive Officer. ... and worked as COO until February of 2014, returned ... other ventures. His return marks a clear dedication to ...
(Date:9/29/2014)... , Sept. 29, 2014  ADM Tronics ... it has entered into an affiliation with Triotech ... Cambridge, Massachusetts founded by ... member of ADMT,s Advisory Board. The ... technology companies with specialized services and finances to ...
Breaking Medicine Technology:Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries 2Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries 3Kush Bottles Co-Founder Steps into Role of CEO 2ADM Tronics Joins Triotech Ventures Technology Consortium 2ADM Tronics Joins Triotech Ventures Technology Consortium 3
(Date:9/30/2014)... If you were to create a list of ... say? Would you place a high value on charisma? Organizational ... a leadership “wish list,” the truth is that just as ... different types of leaders. But if good leaders come in ... that account for this kind of diversity? , PeopleKeys, ...
(Date:9/30/2014)... In a move that will deliver ... and management functions for sponsors, Synergy Research Group ... system. ClinCapture offers advanced out-of-the-box features that will ... trial data and avoid errors and duplications. This ... leading clinical research organization in the Russian region. ...
(Date:9/30/2014)... 2014 Miraca Life Sciences (MLS), the ... research posters at the annual meeting of the American ... its Annual Scientific Meeting and Postgraduate Course in Philadelphia, ... from Miraca Life Sciences will be at booth 711 ... Challenge. , The research posters for ACG provide a ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Pyramid ... announced today that the Department of Veterans Affairs ... as its Enterprise End User Business Intelligence platform. ... support our nation’s veterans by enabling more than ... BI Office’s powerful enterprise analytics and reporting capabilities. ...
(Date:9/30/2014)... Signet Puerto Rico, a leading ... Juan, Puerto Rico, leverages RamSoft’s PowerServer RIS/PACS/PM™ to ... Souffront, site Administrator for Signet Puerto Rico, explains ... to bring in PowerServer RIS/PACS/PM because we will ... physician satisfaction while reducing our costs of delivering ...
Breaking Medicine News(10 mins):Health News:Personality Plays a Key Role in Leadership Development 2Health News:Personality Plays a Key Role in Leadership Development 3Health News:Synergy Research Group Opts for Clinovo 2Health News:Synergy Research Group Opts for Clinovo 3Health News:Miraca Life Sciences Research Institute to Present Eight GI Pathology Research Studies at Annual Meeting of American College of Gastroenterologists 2Health News:U.S. Department of Veterans Affairs Takes Its Analytic Capabilities to the Next Level with BI Office from Pyramid Analytics 2Health News:Signet Puerto Rico Leverages PowerServer RIS/PACS/PM™ to Improve Patient Care, Cut Costs 2
... , NEWARK, N.J., Aug. 6 /PRNewswire-USNewswire / -- ... New Jersey throughout the week of August 9-15 at various cities ... information on programs that provide prescription medicines for free or nearly ... compared to 5.1% a year ago -- the Partnership for Prescription ...
... , NEW YORK, Aug. 6 Care to ... announced today that is has been awarded Full Accreditation in ... nonprofit health care accrediting organization. , , ... of health care management through processes of accreditation and education. ...
... , UNITED NATIONS, Aug. 6 ... Population Fund, are critical to enhancing efforts to reduce maternal ... Representatives of more than 40 international faith-based organizations emphasized ... a policy round table on a range of issues including ...
... Monographs addressing individual mandates, tax exclusion and a public ... of Physicians (ACP). The new policy papers are: ... , Reforming the Tax Exclusion for Health Insurance, A ... "These monographs provide an evidence-based analysis of ...
... , , NEW YORK, Aug. ... now confirmed that America is in a national obesity crisis. More ... America,s well-being, not only as individuals, but as a country. , ... powerful nation when we join together and take a stand. More ...
... , SOUTH PASADENA, Calif., Aug. 6 ... free-standing multi-specialty cancer center in South Pasadena. The 22,000 s.f. ... provide outpatient services in medical, surgical and radiation ... kind in the San Gabriel Valley to offer RapidArc((TM)), a ...
Cached Medicine News:Health News:Partnership for Prescription Assistance Prepared to Help New Jersey Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help New Jersey Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help New Jersey Workers Hurt by Recession 4Health News:Care to Care Receives Full URAC Health Utilization Management Accreditation 2Health News:Care to Care Receives Full URAC Health Utilization Management Accreditation 3Health News:Cooperation Between Faith-Based Organizations and UNFPA Critical to Maternal Health, Say Groups 2Health News:Internists tackle key health reform issues 2Health News:Internists tackle key health reform issues 3Health News:America Takes on the Challenge to Fight Obesity 2Health News:America Takes on the Challenge to Fight Obesity 3Health News:America Takes on the Challenge to Fight Obesity 4Health News:California Cancer Specialists Medical Group, Inc. Opens Outpatient Cancer Center in South Pasadena, Calif., With Renowned Medical Staff, State-of-the-Art Technology 2
... lenses and frames are designed with the safety ... lenses are Schott RS-520 (also called SF-6) leaded ... These lenses meet standards, as set for optical ... ,While our eyewear is protecting your eyes, ...
... Protection Goggles fit over ... used by the whole ... glass, 1.0 mm leaded ... increased scatter radiation protection. ...
... Jarrod Goggles have set the standard ... soft silicone saddle nose bridge. Monel ... and lasts longer. Adjustable elastic headband ... breakable plastic strap clips. 0.75 mm ...
QualCraft™ Euro Lite has a molded nylon frame that fits most faces. Universal keyhole nose bridge fits narrow to average noses. Available with or without lead vinyl-lined side shields....
Medicine Products: